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Purpose: To understand the reasons for differences in the delineation of target volumes between physicians. 
Material and Methods: 18 Swiss radiooncology centers were invited to delineate volumes for one prostate and one head-and-neck 
case. In addition, a questionnaire was sent to evaluate the differences in the volume definition (GTV [gross tumor volume], CTV 
[clinical target volume], PTV [planning target volume]), the various estimated margins, and the nodes at risk. Coherence between 
drawn and stated margins by centers was calculated. The questionnaire also included a nonspecific series of questions regarding 
planning methods in each institution. 
Results: Fairly large differences in the drawn volumes were seen between the centers in both cases and also in the definition of 
volumes. Correlation between drawn and stated margins was fair in the prostate case and poor in the head-and-neck case. The 
questionnaire revealed important differences in the planning methods between centers. 
Conclusion: These large differences could be explained by (1) a variable knowledge/interpretation of ICRU definitions, (2) vari-
able interpretations of the potential microscopic extent, (3) difficulties in GTV identification, (4) differences in the concept, and 
(5) incoherence between theory (i.e., stated margins) and practice (i.e., drawn margins). 
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Die Ursachen unterschiedlicher Markierung der Zielvolumina. Eine SASRO-Studie zu Prostata- und HNO-Karzinomen 
Ziel: Die Ursachen für die unterschiedliche Markierung der Zielvolumina zwischen Ärzten sollten aufgeklärt werden. 
Material und Methodik: 18 schweizerische onkologische Bestrahlungszentren wurden aufgefordert, die Zielvolumina eines 
Prostata- und eines HNO-Karzinoms einzuzeichnen. Ein Fragebogen wurde zusätzlich beigefügt, um die Unterschiede in der Defi-
nition der Volumina (GTV [„gross tumor volume“], CTV [klinisches Zielvolumen], PTV [Planungszielvolumen]) sowie in der Bestim-
mung der Sicherheitssäume und der Risiko-Lymphknotenstationen abzuschätzen. Die Kohärenz zwischen gezeichneten und ge-
planten Sicherheitssäumen wurde berechnet. Der Fragebogen umfasste auch eine Reihe unspezifischer Fragen bezüglich Planungs-
methoden in der jeweiligen Klinik. 
Ergebnisse: Es wurden ziemlich große Unterschiede zwischen gezeichneten und geplanten Sicherheitssäumen festgestellt. Die 
Korrelation war beim Prostatakarzinom mäßig, beim HNO-Fall schwach. Der Fragebogen offenbarte erhebliche Unterschiede in den 
Planungsmethoden zwischen den verschiedenen Kliniken. 
Schlussfolgerung: Diese großen Unterschiede ließen sich durch unterschiedliche Kenntnis/Interpretation 1. der ICRU-Definitio-
nen und 2. der möglichen mikroskopischen Tumorausdehnung, 3. Schwierigkeiten bei der GTV-Erfassung, 4. Unterschiede bezüg-
lich des Konzepts und 5. Inkohärenz zwischen Theorie (d.h. geplante Sicherheitssäume) und Praxis (d.h. gezeichnete Sicherheits-
säume) erklären. 
Schlüsselwörter:  Markierung der Zielvolumina · Strahlentherapie · Prostatakarzinom · HNO-Tumoren 
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Introduction 
Conformal 3-D radiotherapy aims at delivering the largest 
possible and the most homogeneous radiation dose to a tu-
mor target while keeping the dose to surrounding normal tis-
sues to a minimum. Thus, the prime step in radiothera-
py planning is to define and to delineate a target volume in 
three dimensions in order to produce a treatment volume 
which will encompass the tumor with as much precision as 
possible. 
As discussed in more detail elsewhere [18], the routine 
use of 3-D treatment planning in curative radiation therapy 
and the growing implementation of intensity-modulated ra-
diotherapy (IMRT) [5] in many centers or yet in a few cen-
ters proton therapy [17] require a very accurate knowledge 
of the volumes to be treated, with a good reproducibility, 
not only within radiotherapy departments but also between 
departments. Older techniques used larger and unshaped 
fields, and this has led to either a limitation of the total dose 
with many treatment failures or to an excessive rate of com-
plications. Conversely, new technologies, such as IMRT, if 
not associated with an extremely careful definition of the 
target, may lead to an excess of geographic misses and local 
failures. 
The International Commission on Radiation Units and 
Measurements (ICRU) Reports 50 and 62, published in 1993 
and 1999, have provided a formal definition to describe vol-
umes in radiation planning [10, 11]. In brief, the gross tumor 
volume (GTV) is the gross extent of the malignancy. The 
clinical target volume (CTV) is the GTV plus a margin to in-
clude local subclinical tumor spread. The CTV can also in-
clude regional nodes. The GTV and CTV are based on ana-
tomic, biological and clinical considerations and do not 
account for the technical factors of treatment. The planning 
target volume (PTV) is the CTV plus a margin to ensure that 
the CTV receives the prescribed dose. 
Previous studies, including some carried out in our de-
partment, have shown that large discrepancies were found 
when different physicians were asked to delineate volumes in 
the same patient [7, 13, 14, 20, 22, 26–29, 31]. However, few 
studies have tried to analyze and explain the discrepancies re-
lated to differences in medical understanding, knowledge and 
definition of volumes and to all clinical steps that contribute to 
the dose delivery process. These discrepancies are worrisome 
when considering the high precision achieved with conformal 
therapy and even more with IMRT. It has been stated that in-
adequate definition of the GTV/CTV leads to a systematic 
geographic miss of the tumor and that, for some locations, 
these inconsistencies may dominate all other errors in radio-
therapy planning and delivery [31]. To help understand, at 
least in part, the reasons why there are wide variations in vol-
ume delineation between physicians, we undertook a study 
where we chose both an easy case for planning (prostate) and 
a more difficult one (head and neck) and compared the results 
obtained. 
Material and Methods 
18 Swiss radiation oncology centers were invited to partici-
pate in this SASRO study. Clinical and radiologic data of a 
prostate and a head-and-neck case were sent and local physi-
cians were asked to delineate GTV, CTV and PTV according 
to ICRU 50 [10], and to complete a related questionnaire. 
Eleven Swiss centers agreed to participate and have complet-
ed the study. Patient description and CT imaging were sent on 
CD-ROM, along with an ad hoc questionnaire. The two cases 
were the following: 
(1)  a 76-year-old man with a PSA (prostate-specific antigen) 
6, Gleason 4, stage T1c N0 M0 prostatic adenocarcino-
ma; 
(2)  a 72-year-old man with a well-differentiated squamous cell 
carcinoma of the base of the tongue, stage T3 N0 M0. 
Anonymous data analysis and interpretation were ensured. 
In brief, the physical part of the study was based on the analysis 
of the consistency of the delineated volumes in a two-step pro-
cedure. The first included examination of 2-D contour deline-
ation in the three main planes and calculation of their extensi-
on in the three main axes. In the second step, the correlation 
of the volume delineation made at the different institutions 
was established [18]. 
Questionnaire Specific to the Two Cases 
In this part of the questionnaire, physicians were asked how 
they would specifically define the GTV in each of the two 
situations and if they had difficulty in defining it, especially 
concerning its various limits in space. With regard to the 
CTV, besides specific definition, questions were related to 
the distance (margin) in millimeters between GTV and CTV 
physicians would use in the two cases, and if any (and 
which) adjacent organ(s) had to be excluded from the 
CTV. With regard to the PTV, physicians had to give the 
relevant definition and the margin estimate in all directions. 
For the head-and-neck case, physicians had to name the 
lymph nodes at risk to be encompassed in the volume irradi-
ated. In the final analysis, we looked not only at the inter-
center variations between volumes [18], but also at the in-
traobserver coherence between the volumes drawn and the 
answers given in the questionnaire (i.e., margins drawn and 
stated). 
Questionnaire with General Information 
not Specifically Related to the Two Cases 
Although each physician received the same material for the 
purpose of this study, we also wanted to know the differences 
in concept and in the routine planning between each individ-
ual institution. This part of the questionnaire therefore con-
tained questions on CT planning techniques (use of contrast, 
interval between slices), how the GTV is generally estab-
lished (use of additional diagnostic tools, possible help from 
other colleagues such as radiologists or surgeons), and the use 
of immobilization devices. 
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Poststudy Questionnaire 
Once all results concerning the volumes had been collected 
from the institutions and analyzed, anonymized transverse and 
sagittal delineation of prostate and head-and-neck volumes of 
all centers were sent to each physician with a new questionnaire. 
Physicians were asked to analyze the differences between all 
volumes drawn and to comment. They were asked to compare 
their own volume to that of other centers and to state if they still 
thought that their delineation was the best. 
They were also invited to formulate their 
own hypothesis as to the possible causes 
for these large volume discrepancies. 
Results 
Volumes Drawn 
As expected, there were wide variations 
between the volumes drawn by the elev-
en physicians. Regarding the prostate 
case, the mean CTV was 105.3 cm3, with a 
minimum of 39.9 and a maximum of 180.5 
cm3, the mean PTV was 218.2 cm3 (mini-
mum 149.7, maximum 289.1 cm3; Figures 
1a and 1b). With regard to the head-and-
neck case, the mean GTV was 46.4 cm3 
(minimum 19.0, maximum 63.8 cm3), the 
mean CTV 327.0 cm3 (minimum 119.7, 
maximum 601.6 cm3), and the mean PTV 
527.5 cm3 (minimum 364.7, maximum 
654.0 cm3; Figures 1c and 1d). 
Responses to the Questionnaire 
Specific to the Two Cases 
(Eleven Centers) 
Definition of the GTV 
The answers for the GTV definition 
were inconsistent in both situations. In 
three centers, GTV was said to represent 
the prostate, in five the prostate and the 
seminal vesicles, and three gave an in-
valid answer. As far as the head-and-
neck case is concerned, four centers con-
sidered the macroscopic tumor only, one 
the tumor plus one lymph node (on the 
basis of their own CT interpretation), 
and six gave an invalid answer. 
Difficulties in GTV Evaluation 
Regarding the prostate case, eight of the 
eleven physicians stated that they had no 
difficulty in identifying the GTV on the 
CT, whereas for the head-and-neck case, 
only five of eleven had no difficulty. 
Definition of CTV, Organ Exclusion 
For the prostate case, six physicians con-
sidered the CTV to be equal to the GTV 
(i.e., the prostate or in some cases the 
prostate plus the seminal vesicles), four 
Figures 1a to 1d. Demonstration of the variations in the CTV delineation on axial and sagittal 
planes for the prostate (a, b) and the head-and-neck case (c, d). 
Abbildungen 1a bis 1d. Darstellung der Abweichungen bei der Bestimmung des CTV in den 
frontalen und sagittalen Ebenen beim Prostata- (a, b) und HNO-Karzinom (c, d). 
a b
c d
Figures 2a and 2b. Distribution of reported margins around GTV for extracting the CTV for the 
prostate (a) and the head-and-neck case (b). 
Abbildungen 2a und 2b. Verteilung der um das GTV gezeichneten Sicherheitssäume bei der 
Bestimmung des CTV beim Prostata- (a) und HNO-Karzinom (b).
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stated it was the GTV plus a margin, and one answer was in-
valid. The mean stated value of the margin between GTV and 
CTV was 4.1 mm (minimum 0, maximum 10 mm; Figure 2a). 
For the head-and-neck case, the CTV was defined as the 
GTV plus a margin in five, and CTV plus a margin plus the 
lymph nodes in four centers, and two responses were in-
valid. The median stated margin between GTV and CTV was 
10.2 mm (Figure 2b). In eight head-and-neck situations, one or 
more organs were said to be excluded from CTV (five spinal 
cords, two bony structures, two parotids, one larynx, and one 
oropharynx). Three physicians did not state if they would ex-
clude normal structures from CTV.  
Head-and-Neck Lymph Nodes 
Here, ten of twelve physicians gave fairly consistent responses 
(Table 1). Only one physician considered not to treat bilateral 
lymph nodes, and two considered not to include the supracla-
vicular and the inferior jugular areas. 
PTV Margins 
For the prostate case, physicians were asked to give a margin 
in three dimensions. The median stated values of margins be-
tween CTV and PTV were 9.4 mm (minimum 5, maximum 
14 mm), 11.0 mm (minimum 5, maximum 14 mm), and 9.1 mm 
(minimum 5, maximum 14 mm) in the anteroposterior (AP), 
craniocaudal (CC) and lateral (LAT) directions, respectively, 
with fairly wide differences between investigators (Figure 3a). 
As far as the head-and-neck case is concerned, only one mar-
gin value was asked for. The median stated value between CTV 
and PTV was 7.0 mm (minimum 5, maximum 10; Figure 3b). 
Intraobserver Coherence 
For each institution, we measured the margins (GTV-CTV 
and CTV-PTV) drawn on the planning CT and compared 
them to the margins stated by the physician of that same insti-
tution. There was a good coherence for the prostate case ex-
cept for one investigator (margin contoured: 5 mm, margin 
stated: 10 mm; Figure 4a). 
With regard to the head-and-neck 
case, the intraobserver coherence was, 
on average, worse than that for the pros-
tate case, most physicians drawing wider 
margins than those they had stated (Fig-
ure 4b). 
Responses to the Questionnaire 
not Specifically Related to the 
Two Cases (Eleven Centers) 
CT for Planning 
When using CT for planning in prostate 
cancer, only three of eleven centers use 
contrast material. The median interval 
between CT slices is 5.8 (± 2.4) mm 
(range 3–10 mm). 
For head-and-neck cancer planning, also three of eleven 
centers use contrast for dedicated CT, and the median interval 
between slices is 5.9 (± 2.1) mm (range 3–10 mm).
Establishment of GTV 
When planning for prostate cancer, four centers routinely 
use other diagnostic tools (MRI, ultrasound) to define the 
GTV, and four ask for the help of a colleague from another 
specialty (i.e., radiologist). 
For head-and-neck cancer planning, the large majority of 
physicians (ten of eleven) use other means (MRI, positron 
emission tomography [PET], endoscopic examination) and six 
out of eleven would associate a colleague from another spe-
cialty (i.e., head-and-neck surgeon, radiologist) to draw the 
GTV. 
Immobilization Devices 
In routine prostate cancer radiotherapy, six centers use an im-
mobilization device including a rectal balloon in one. For ex-
Table 1. Results of the questionnaire on lymph nodes at risk in the 
T3 N0 M0 base-of-tongue cancer. Participants were asked to define 
the lymph node(s) group(s) they consider to be at risk of microscopic 
involvement (ten answers). 
Tabelle 1. Ergebnisse des Fragebogens bezüglich Risiko-Lymphknoten-
stationen beim T3 N0 M0-Zungengrundkarzinom. Die Teilnehmer 
wurden aufgefordert, die ihrer Meinung nach mit einem Risiko mikro-
skopischer Ausdehnung behafteten Lymphknotenstationen zu bestim-
men (zehn Antworten). 
Lymph node areas Yes, homolateral Yes, bilateral No 
Supraclavicular 0   8 2
Inferior jugular 0   7 2
Midjugular 1   9 0
Subdigastric 0 10 0
Superior jugular 0 10 0
Spinal 0   9 1
Submaxillary 0   9 1
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Figures 3a and 3b. Distribution of reported margins to be applied on CTV for defining the PTV 
for the prostate (a) and the head-and-neck case (b). 
Abbildungen 3a und 3b. Verteilung der um das CTV gezeichneten Sicherheitssäume bei der 
Bestimmung des PTV beim Prostata- (a) und HNO-Karzinom (b). 
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ternal immobilization, a thermoplastic cast and a device to 
support the legs is reported to be used. 
All centers that participated routinely use an immobiliza-
tion device (mask) for the treatment of head-and-neck cancer 
patients. 
Answers to the Poststudy Questionnaire 
The poststudy questionnaire was answered by only four physi-
cians. After having reviewed their own delineation and com-
pared it to those of other centers, two physicians would modify 
their CTV for the prostate case, and all four would change 
their head-and-neck volumes. Regarding the reasons for these 
large intercenter discrepancies in volume delineation, the fol-
lowing explanations were given: (1) insufficient quality of the 
images provided for the study, (2) lack of knowledge of ICRU 
definitions, and (3) variable clinical experience amongst phy-
sicians. 
Discussion 
Large variations in volume definition related to intra- and in-
terobserver variability in contouring tumor targets are a 
well-known fact. These variations have been shown in many 
cancer sites, such as lung, prostate, brain, head-and-neck, 
esophagus and cervix [7, 13, 14, 19, 22, 24, 26–29, 32]. The mag-
nitude of the discrepancies may vary from site to site, but for 
some locations, they may represent a major cause of error in 
radiotherapy planning and, consequently, a principal cause of 
treatment failure. 
Although a number of hypotheses were made regarding 
the possible reasons for those physician-to-physician varia-
tions, as reviewed by Weiss & Hess [31], only a few studies 
have been carried out in an attempt to identify the reasons for 
these discrepancies [19, 20]. In this study, in which we confirm 
wide interobserver variations in a prostate and a head-and-
neck case [18], we aimed to identify at least some of the rea-
sons of these variations: (a) by using an apparently simple case 
(T1c N1 M0 carcinoma of the prostate) 
and a more difficult case (cT3 N0 M0 
carcinoma of the base of tongue) and 
compare their relative interobserver 
variations, (b) by sending an ad hoc 
questionnaire with a series of questions 
related to each step (GTV, CTV, PTV) 
of the volume definition, and by compar-
ing the answers given by each investiga-
tors, and, finally, (c) by correlating the 
answers given by individual physicians 
to their own displayed volumes. 
Comparison between the Prostate 
and the Head-and-Neck Case 
Although we had expected large in-
terobserver variations in the base-of-
tongue cancer case, we were surprised to 
see also significant differences in all volumes in the apparently 
easy prostate example. Previous reports have suggested wider 
discrepancies in volumes in head-and-neck cancers [15, 27] 
than in prostate cancer [6, 7]. 
However, our hypothesis that a rather simple oncologic 
and radiologic situation will lead to less interobserver varia-
tion than a more complex one could not be readily confirmed 
in this study. 
GTV Definition 
Responses concerning GTV definition were inconsistent in 
both cases. Even with a relatively small number of physicians 
(eleven), it is striking to see how differently the ICRU recom-
mendations have been interpreted for these two examples. In 
spite of this, eight of eleven physicians felt comfortable in 
identifying the prostate GTV, whereas less than half had no 
difficulty with the head-and-neck case. This is also reflected by 
the fact that six of eleven physicians would routinely associate 
a colleague from another specialty (radiologist, surgeon) while 
delineating head-and-neck target volume on CT. 
Valicenti et al. [26] showed that there was an excellent 
agreement amongst observers in defining the prostate target 
volume, but poor agreement in that of the seminal vesicles. 
This, and the fact that in our case physicians were of different 
opinion with regard to GTV definition, could explain the un-
expected wide GTV differences found in the prostate case. 
Imaging data are of crucial importance for the definition 
of GTV. The use of contrast material for CT planning increas-
es detectability and helps to define the borders of the malig-
nancy or of an organ like the prostate [26, 31]. In spite of this, 
only three physicians involved in our study state that they use 
it routinely in either situation. The variability of CT slice inter-
vals and different use of additional diagnostic tools also reflect 
large differences in local planning habits. 
The use of MRI in addition to CT has been shown to im-
prove the accuracy of GTV both in prostate and head-and-neck 
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cancer planning [16, 19] to decrease interobserver variation 
[26, 30], and, finally, to reduce the GTV [19–21]. The addition 
of PET and choline and acetate PET in case of prostate can-
cer may also offer further advantages in terms of tumor delin-
eation [9]. 
CTV Definition 
As for GTV, CTV definitions were inconsistent in both cas-
es. In the ICRU 50 Report, it is stated that the CTV can in-
clude regional lymph nodes. Later in the questionnaire, all 
(eleven) investigators answered they would electively treat 
draining nodes, although only four physicians previously 
considered these part of the CTV. There was no agreement 
between investigators regarding CTV definition either in the 
prostate or in the base-of-tongue case. With regard to the 
margins between the GTV and CTV, the values reported 
were, on average, smaller (4.1 mm) for the prostate than for 
the head-and-neck case (10.2 mm), with less variation for the 
latter. 
Thus, microscopic extent beyond the GTV was presumed 
to be smaller in case of prostate cancer than in case of 
base-of-tongue cancer. In a study by The et al. [25], extracap-
sular extension was found in 42% of 712 patients undergoing 
prostatectomy, and the median radial extension was 2 mm 
(range 0.5–12 mm).
It is well recognized that oral and base-of-tongue cancers 
can be very infiltrative. Using the criteria by Anneroth et al. 
[1], Spiro et al. [23], in 137 surgical specimens of oral tongue 
cancers, demonstrated that 44 had a grade 3 pattern (margins 
containing small groups of cords of infiltrating cells) and 47 
had grade 4 (marked cellular dissociation in small groups or 
even single cells). Base-of-tongue cancers are generally less 
differentiated, even more infiltrative and more advanced than 
oral tongue cancers [3]. Thus, a wider surgical or radiotherapy 
margin is deemed necessary. 
The estimate of GTV-CTV margins can be hampered by 
a number of uncertainties, because microscopic extent can be 
extremely variable: depending on tumor type and site, micro-
scopic disease can mean nodal, perineural, perivascular, in-
tramuscular, intraparenchymal, perilymphatic, or bony ex-
tent. Imaging techniques are currently incapable of directly 
detecting areas of subclinical tumor involvement [4]. There-
fore, the estimate of microscopic extent depends much on 
previous experience, based on pathologic studies of surgical 
specimens, or on patterns of failure after surgery or radio-
therapy. This also accounts for the great variability in 
GTV-CTV margins between physicians. In our study, this is 
reflected by the fact that there was no agreement concerning 
the organs that should be excluded from the CTV (= “non-
target organs”). Subclinical nodal involvement was not con-
sidered in this early prostatic case, but certainly in the case of 
the T3 N0 M0 base-of-tongue cancer: for such a case, the 
lymph node CTV would include the anterior cervical chain, 
the spinal accessory nodes, the jugular nodes, the posterior 
submandibular nodes, and the supraclavicular nodes [15]. For 
the latter there was, surprisingly, a relatively good agreement 
regarding the lymph nodes deemed to be at risk of microscop-
ic disease (see Table 1). This was perhaps facilitated by the 
fact that the case was that of a fairly large tumor with exten-
sion onto the midline, an indication for bilateral neck node 
irradiation [8]. The decision regarding the various levels of 
lymph nodes to be treated in the various head-and-neck can-
cers is a very complex one. In this respect, the groups at UCL, 
Brussels, Belgium [8], and Rotterdam, The Netherlands [33], 
have published excellent and comprehensive guidelines for 
the selection and delineation of lymph node target volumes in 
head-and-neck conformal radiotherapy. So, according to 
Grégoire et al., for a case of T3 N0 M0 base-of-tongue cancer, 
the CTV (with regard to the nodes) should include the lym-
phatics of levels IB, II, III, and IV on both sides of the neck, 
whereas level V should be included only if levels II and III are 
involved [8]. 
PTV Margins 
In the prostate example, the stated margins between CTV and 
PTV in three dimensions varied considerably (Figure 3a). If 
related to literature data, the median stated values of 9.4 mm 
for AP, 11 mm for CC and 9 mm for LAT margins appear to 
be safe. Antolak et al. [2] have reported their measurement of 
the mobility of prostate CTV in three directions and summa-
rized their data and those available from other groups. The 
translation in AP axis varied from 0.15 to 0.52 cm, in CC from 
0.17 to 0.50 cm, and in LAT from 0.08 to 0.27 cm. 
It should be noted that the PTV accounts not only for 
physiological movements of tissues containing or surrounding 
the CTV, but also of patient’s motion during treatment, and of 
day-to-day variation in patient setup, so the larger margins 
found in our exercise appear altogether reasonable. 
In the head-and-neck case, the stated CTV-PTV margins 
were also quite variable (see Figure 3b). Five centers state 
they would add a 5-mm margin and three centers a 10-mm 
margin. 
Contrary to prostate cancer, there have been very few 
studies on tissue mobility in case of base-of-tongue cancer, 
relevant to radiotherapy. In a group of 60 male and female 
normal controls, the mean hyoid displacement when swallow-
ing 1 cm3 of liquid was 1.69 cm [12]. In a series of 20 patients 
who had received radiotherapy, mobility was decreased [12], 
but unfortunately, no data were obtained on patients with 
base-of-tongue cancer prior to treatment, to evaluate wheth-
er the presence of tumor per se would decrease mobility. 
In our study, however, a 5-mm margin for PTV would ap-
pear tight in the case of the base-of-tongue cancer. 
Intraobserver Coherence 
Contrary to the other data of our study, there was a clear dif-
ference between the coherence results of the prostate and of 
the head-and-neck case (see Figures 4a and 4b). In general, for 
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the prostate exercise, physicians drew margins similar to those 
which they had stated, whereas for the head-and-neck situa-
tion, they tended to draw larger GTV-CTV and CTV-PTV 
margins than the values they have stated. 
Conclusion 
In this study, we confirmed that wide interobserver variations 
exist in the delineation of GTV, CTV and PTV, in two differ-
ent oncologic cases. 
Data to explain these discrepancies are scarce in the lit-
erature and suggest multifactorial and complex reasons. We 
suggest that part of these are due to: 
(1)  a variable knowledge and/or interpretation in the basic 
ICRU definitions; 
(2)  difficulties in the identification of GTV due to the avail-
able imaging quality; 
(3)  a variable understanding and/or concept for microscopic 
tumor extent (CTV); 
(4)  a variable knowledge and/or concept in the estimation of 
variations in position and movement of the CTV (GTV); 
(5)  a variable coherence between the theoretical knowledge 
(stated margins) and the practice (drawn margins). 
Conceivably, measures can be taken to decrease discrep-
ancies and, hopefully, improve interobserver coherence. To 
start with, a better and more comprehensive diffusion and 
understanding of ICRU recommendations in the radiation 
oncology community should be promoted. In parallel, con-
tinuous research in cancer imaging, in the knowledge of mi-
croscopic tumor extent and in a more systematic and indi-
vidualized estimation of physiological motion should be 
supported. 
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